Mabwell Bioscience Secures Licensing Deals for Denosumab Biosimilars in Egypt and Pakistan
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced separate licensing and commercialization agreements...
GeneMind Biosciences Secures RMB 400 Million in Series C Financing to Expand Gene Testing
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in...
Guangzhou Wondfo Biotech Partners with Indonesia’s Kimia Farma in IVD Field
China-based Guangzhou Wondfo Biotech Co., Ltd (SHE: 300482) has entered into a partnership with Indonesia’s...
InxMed Partners with GeneQuantum Healthcare to Develop Innovative ADCs
China-based firm InxMed (Nanjing) Co., Ltd has announced a strategic partnership with compatriot firm GeneQuantum...
Sansure Biotech Partners with Indonesian Firm for Localized Molecular Diagnostic Production
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced a strategic partnership with...
Sinopharm Partners with Harbin Institute of Technology to Boost Biomedical Industry Innovation
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Harbin...
NK Celltech and RongCan Biotech Partner to Advance mRNA NK Cell Therapy and LNP Delivery System
Shanghai-based NK Celltech and RongCan Biotech have entered into a partnership agreement to establish a...
Abbisko Therapeutics Initiates Phase II Clinical Trial for Pimicotinib in Tendon Sheath Giant Cell Tumor
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced the dosing of the first...
CASI Pharmaceuticals Enters Assignment Agreement with Mundipharma for Folotyn Commercialization in China
US-based CASI Pharmaceuticals Inc., (NASDAQ: CASI) has announced the execution of an assignment agreement with...
Astellas Pharma’s Zolbetuximab BLA Accepted by China’s CDE for Gastric Cancer Treatment
Japan-based Astellas Pharma Inc. (TYO: 4503) has announced that the Center for Drug Evaluation (CDE)...
Shanghai Junshi Biosciences Partners with Zein Biotechnology for PCSK9 mAb Commercialization in China
China-based Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has announced a partnership with...
MSD’s Q2 2023 Earnings: Keytruda and Gardasil Drive Growth Amid COVID-19 Sales Decline
US-based major Merck, Sharp & Dohme Inc., (MSD; NYSE: MRK) has released its financial results...
GluBio Pharmaceutical Secures $22 Million in A+ Round Financing to Advance Protein Degradation Drugs
GluBio Pharmaceutical Co., Ltd., an emerging player in targeted protein degradation drug development, has announced...
GSK’s Jemperli Receives FDA Approval for First-Line Treatment of Advanced Endometrial Cancer
GSK plc (NYSE: GSK), a major UK pharmaceutical company, has announced that the US Food...
Viatris Inc. Secures FDA Nod for Generic Symbicort Equivalent, Breyna
US-based Viatris Inc., (NASDAQ: VTRS) has announced that the US Food and Drug Administration (FDA)...
Mindray Bio-Medical Electronics to Acquire Majority Stake in DiaSys Diagnostic Systems
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading medical device company based in...
EnChannel Secures RMB 200 Million in Series A Funding to Advance Electrophysiology Solutions
EnChannel Medical, a Guangzhou-based electrophysiology platform company, has reportedly secured RMB 200 million (USD 28...
Sinovation Secures Over RMB 100 Million in Series D+ Financing for Neurosurgery Innovations
Beijing-based Sinovation (Beijing) Medical Technology Co., Ltd., a leader in neurosurgery diagnosis, minimally invasive procedure...
Peijia Medical Commences Clinical Study for Taurus Trio TAVR System with First Patient Enrollment
Peijia Medical Ltd (HKG: 9996) has announced the enrollment of the first patient in a...
RemeGen’s Novel Bispecific Antibody RC148 Receives Clinical Trial Approval
China-based RemeGen Ltd (SHA: 688331, HKG: 9995) has announced that it has received clinical trial...